Hunter T
Molecular Biology and Virology Laboratory, Salk Institute, La Jolla, CA 92037, USA.
Philos Trans R Soc Lond B Biol Sci. 1998 Apr 29;353(1368):583-605. doi: 10.1098/rstb.1998.0228.
The reversible phosphorylation of tyrosines in proteins plays a key role in regulating many different processes in eukaryotic organisms, such as growth control, cell cycle control, differentiation cell shape and movement, gene transcription, synaptic transmission, and insulin action. Phosphorylation of proteins is brought about by enzymes called protein-tyrosine kinases that add phosphate to specific tyrosines in target proteins; phosphate is removed from phosphorylated tyrosines by enzymes called protein-tyrosine phosphatases. Phosphorylated tyrosines are recognized by specialized binding domains on other proteins, and such interactions are used to initiate intracellular signaling pathways. Currently, more than 95 protein-tyrosine kinases and more than 55 protein-tyrosine phosphatase genes are known in Homo sapiens. Aberrant tyrosine phosphorylation is a hallmark of many types of cancer and other human diseases. Drugs are being developed that antagonize the responsible protein-tyrosine kinases and phosphatases in order to combat these diseases.
蛋白质中酪氨酸的可逆磷酸化在真核生物中调节许多不同过程发挥关键作用,如生长控制、细胞周期控制、细胞分化、细胞形状和运动、基因转录、突触传递及胰岛素作用。蛋白质的磷酸化由称为蛋白酪氨酸激酶的酶引发,这些酶将磷酸基团添加到靶蛋白的特定酪氨酸上;磷酸基团则由称为蛋白酪氨酸磷酸酶的酶从磷酸化的酪氨酸上去除。磷酸化的酪氨酸被其他蛋白质上的特异性结合结构域识别,此类相互作用用于启动细胞内信号通路。目前,在智人中已知有超过95种蛋白酪氨酸激酶和超过55种蛋白酪氨酸磷酸酶基因。异常的酪氨酸磷酸化是许多类型癌症和其他人类疾病的一个标志。正在研发拮抗相关蛋白酪氨酸激酶和磷酸酶的药物以对抗这些疾病。